Form D · Biotechnology
Scilex Holding Co
Palo Alto, CA · CIK 0001820190
Offering snapshot reported Oct 14, 2025 · SEC filing
- Reported sold
- $2.69M Offering amount: $2.69M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 30, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 14, 2025 | Initial | $2,688,540 | No comparison | 2 | SEC filing |
| Oct 5, 2023 | Initial | $101,875,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-560724
The above offering amount represents the aggregate exercise price of existing warrants that were exercised, for which the warrants in this offering were issued as an inducement.
Source: Form D, filed Oct 14, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jay Chun | Director |
| Dorman Followwill | Director |
| Henry Ji | Director, Executive |
| David Lemus | Director |
| Stephen Ma | Director, Executive |
| Jaisim Shah | Director, Executive |
| Yue Alexander Wu | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
960 San Antonio Road
Palo Alto, CA, 94303
Palo Alto, CA, 94303